Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if EWTX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
45 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 61 days ago
Red flags: 13
227 filers reported a long position in EWTX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| ORBIMED ADVISORS LLC | $630.5M | 15.5M | Unchanged |
| Paradigm Biocapital Advisors LP | $415.1M | 10.2M | +38.7% |
| RA CAPITAL MANAGEMENT, L.P. | $341M | 8.4M | -19.5% |
| BlackRock, Inc. | $268.4M | 6.6M | +2.1% |
| Jupiter Topco LLC | $246.9M | 6.1M | — |
| FMR LLC | $223M | 5.5M | +439.7% |
| Novo Holdings A/S | $217.4M | 5.4M | Unchanged |
| DRIEHAUS CAPITAL MANAGEMENT LLC | $192.1M | 4.7M | +5.6% |
| PERCEPTIVE ADVISORS LLC | $177.7M | 4.4M | -1.1% |
| VANGUARD CAPITAL MANAGEMENT LLC | $156.9M | 3.9M | +1.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.